GS

Gulam Subhani Gulam Jilani Shaikh

Director Director DIN 08276237
DIN 08276237 First appointment Nov 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Nov 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Gulam Subhani Gulam Jilani Shaikh

Data last updated:

Gulam Subhani Gulam Jilani Shaikh was a Director at Benever Pharma Private Limited (2018–2021). The company operates in Business Services.

DIN 08276237
Primary Designation Director
Industry Business Services
First Appointment 12 Nov 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Benever Pharma Private Limited U74999MH2018PTC314127
Director12 Nov 20182018₹11.8 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Benever Pharma Private Limited
Premium access

Shareholding and investment profile for Gulam Subhani Gulam Jilani Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gulam Subhani Gulam Jilani Shaikh

Gulam Subhani Gulam Jilani Shaikh was first appointed on 12 Nov 2018 as Director at Benever Pharma Private Limited.

Gulam Subhani Gulam Jilani Shaikh held 1 earlier board appointment: Benever Pharma Private Limited (Director, 12 Nov 2018 to 02 Dec 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available